Diag-Nose.io launches Houston office to advance precise respiratory care using AI and proteomics after a successful $2M seed round HOUSTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Diag-Nose.io, a ...
Diag-Nose.io sets new standards in respiratory care with AI and proteomics after a $2M seed funding success, now expanding to Bethlehem, PA BETHLEHEM, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- A ...
30, 2025 (GLOBE NEWSWIRE) -- A groundbreaking precision medicine system developed by biotech trailblazer Diag-Nose.io hopes to transform the management of chronic respiratory diseases worldwide ...